Literature DB >> 31114909

A new normalization for Nanostring nCounter gene expression data.

Ramyar Molania1,2,3, Johann A Gagnon-Bartsch4, Alexander Dobrovic1,5,6,7, Terence P Speed2,8.   

Abstract

The Nanostring nCounter gene expression assay uses molecular barcodes and single molecule imaging to detect and count hundreds of unique transcripts in a single reaction. These counts need to be normalized to adjust for the amount of sample, variations in assay efficiency and other factors. Most users adopt the normalization approach described in the nSolver analysis software, which involves background correction based on the observed values of negative control probes, a within-sample normalization using the observed values of positive control probes and normalization across samples using reference (housekeeping) genes. Here we present a new normalization method, Removing Unwanted Variation-III (RUV-III), which makes vital use of technical replicates and suitable control genes. We also propose an approach using pseudo-replicates when technical replicates are not available. The effectiveness of RUV-III is illustrated on four different datasets. We also offer suggestions on the design and analysis of studies involving this technology.
© The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Year:  2019        PMID: 31114909      PMCID: PMC6614807          DOI: 10.1093/nar/gkz433

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  23 in total

1.  Using control genes to correct for unwanted variation in microarray data.

Authors:  Johann A Gagnon-Bartsch; Terence P Speed
Journal:  Biostatistics       Date:  2011-11-17       Impact factor: 5.899

2.  NanoStringNorm: an extensible R package for the pre-processing of NanoString mRNA and miRNA data.

Authors:  Daryl Waggott; Kenneth Chu; Shaoming Yin; Bradly G Wouters; Fei-Fei Liu; Paul C Boutros
Journal:  Bioinformatics       Date:  2012-04-17       Impact factor: 6.937

3.  What is principal component analysis?

Authors:  Markus Ringnér
Journal:  Nat Biotechnol       Date:  2008-03       Impact factor: 54.908

4.  Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue.

Authors:  David W Scott; George W Wright; P Mickey Williams; Chih-Jian Lih; William Walsh; Elaine S Jaffe; Andreas Rosenwald; Elias Campo; Wing C Chan; Joseph M Connors; Erlend B Smeland; Anja Mottok; Rita M Braziel; German Ott; Jan Delabie; Raymond R Tubbs; James R Cook; Dennis D Weisenburger; Timothy C Greiner; Betty J Glinsmann-Gibson; Kai Fu; Louis M Staudt; Randy D Gascoyne; Lisa M Rimsza
Journal:  Blood       Date:  2014-01-07       Impact factor: 22.113

Review 5.  Principal component analysis: a review and recent developments.

Authors:  Ian T Jolliffe; Jorge Cadima
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2016-04-13       Impact factor: 4.226

6.  Molecular classification of Crohn's disease reveals two clinically relevant subtypes.

Authors:  Matthew Weiser; Jeremy M Simon; Bharati Kochar; Adelaide Tovar; Jennifer W Israel; Adam Robinson; Gregory R Gipson; Matthew S Schaner; Hans H Herfarth; R Balfour Sartor; Dermot P B McGovern; Reza Rahbar; Timothy S Sadiq; Mark J Koruda; Terrence S Furey; Shehzad Z Sheikh
Journal:  Gut       Date:  2016-10-14       Impact factor: 23.059

7.  ERCC1 and RRM1 in the international adjuvant lung trial by automated quantitative in situ analysis.

Authors:  Gerold Bepler; Ken André Olaussen; Anne-Lise Vataire; Jean-Charles Soria; Zhong Zheng; Ariane Dunant; Jean-Pierre Pignon; Michael J Schell; Pierre Fouret; Robert Pirker; Martin Filipits; Elisabeth Brambilla
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

8.  ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine.

Authors:  P Ceppi; M Volante; S Novello; I Rapa; K D Danenberg; P V Danenberg; A Cambieri; G Selvaggi; S Saviozzi; R Calogero; M Papotti; G V Scagliotti
Journal:  Ann Oncol       Date:  2006-09-15       Impact factor: 32.976

9.  limma powers differential expression analyses for RNA-sequencing and microarray studies.

Authors:  Matthew E Ritchie; Belinda Phipson; Di Wu; Yifang Hu; Charity W Law; Wei Shi; Gordon K Smyth
Journal:  Nucleic Acids Res       Date:  2015-01-20       Impact factor: 16.971

10.  Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis.

Authors:  C L Noble; A R Abbas; J Cornelius; C W Lees; G-T Ho; K Toy; Z Modrusan; N Pal; F Zhong; S Chalasani; H Clark; I D Arnott; I D Penman; J Satsangi; L Diehl
Journal:  Gut       Date:  2008-06-03       Impact factor: 23.059

View more
  20 in total

1.  Identifying the Transcriptional Response of Cancer and Inflammation-Related Genes in Lung Cells in Relation to Ambient Air Chemical Mixtures in Houston, Texas.

Authors:  Lauren A Eaves; Hang T Nguyen; Julia E Rager; Kenneth G Sexton; Thomas Howard; Lisa Smeester; Anastasia N Freedman; Kjersti M Aagaard; Cynthia Shope; Barry Lefer; James H Flynn; Mathew H Erickson; Rebecca C Fry; William Vizuete
Journal:  Environ Sci Technol       Date:  2020-10-16       Impact factor: 9.028

2.  RCRdiff: A fully integrated Bayesian method for differential expression analysis using raw NanoString nCounter data.

Authors:  Can Xu; Xinlei Wang; Johan Lim; Guanghua Xiao; Yang Xie
Journal:  Stat Med       Date:  2021-11-12       Impact factor: 2.373

3.  RUV-III-NB: normalization of single cell RNA-seq data.

Authors:  Agus Salim; Ramyar Molania; Jianan Wang; Alysha De Livera; Rachel Thijssen; Terence P Speed
Journal:  Nucleic Acids Res       Date:  2022-09-09       Impact factor: 19.160

4.  Checkpoint inhibitor immunotherapy diminishes oocyte number and quality in mice.

Authors:  Amy L Winship; Lauren R Alesi; Sneha Sant; Sherene Loi; Karla J Hutt; Jessica M Stringer; Aldana Cantavenera; Teharn Hegarty; Carolina Lliberos Requesens; Seng H Liew; Urooza Sarma; Meaghan J Griffiths; Nadeen Zerafa; Stephen B Fox; Emmaline Brown; Franco Caramia; Pirooz Zareie; Nicole L La Gruta; Kelly-Anne Phillips; Andreas Strasser
Journal:  Nat Cancer       Date:  2022-08-25

5.  Removing unwanted variation from large-scale RNA sequencing data with PRPS.

Authors:  Anthony T Papenfuss; Terence P Speed; Ramyar Molania; Momeneh Foroutan; Johann A Gagnon-Bartsch; Luke C Gandolfo; Aryan Jain; Abhishek Sinha; Gavriel Olshansky; Alexander Dobrovic
Journal:  Nat Biotechnol       Date:  2022-09-15       Impact factor: 68.164

6.  An approach for normalization and quality control for NanoString RNA expression data.

Authors:  Arjun Bhattacharya; Alina M Hamilton; Helena Furberg; Eugene Pietzak; Mark P Purdue; Melissa A Troester; Katherine A Hoadley; Michael I Love
Journal:  Brief Bioinform       Date:  2021-05-20       Impact factor: 11.622

7.  Mid-pregnancy maternal blood nitric oxide-related gene and miRNA expression are associated with preterm birth.

Authors:  Tracy A Manuck; Lauren A Eaves; Julia E Rager; Rebecca C Fry
Journal:  Epigenomics       Date:  2021-04-23       Impact factor: 4.778

8.  Urinary miRNA profiles discriminate between obstruction-induced bladder dysfunction and healthy controls.

Authors:  Michelle von Siebenthal; Mustafa Besic; Ali Hashemi Gheinani; Akshay Akshay; Salomé Lizun-Platoni; Nadine Kunz; Fiona C Burkhard; Katia Monastyrskaya
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

9.  Protocol for the processing and downstream analysis of phosphoproteomic data with PhosR.

Authors:  Hani Jieun Kim; Taiyun Kim; Di Xiao; Pengyi Yang
Journal:  STAR Protoc       Date:  2021-06-05

10.  Nitric oxide-related gene and microRNA expression in peripheral blood in pregnancy vary by self-reported race.

Authors:  Tracy A Manuck; Lauren A Eaves; Julia E Rager; Karen Sheffield-Abdullah; Rebecca C Fry
Journal:  Epigenetics       Date:  2021-07-24       Impact factor: 4.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.